Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag FDA recalls 580K prazosin bottles over cancer-linked impurity; no illnesses reported.

flag The U.S. FDA has recalled over 580,000 bottles of prazosin, a blood pressure medication, due to contamination with N-nitroso prazosin impurity C, a nitrosamine linked to cancer in animal studies. flag The recall affects 1 mg, 2 mg, and 5 mg capsules from specific lots distributed nationwide, with no illnesses reported. flag Classified as a Class II recall, the risk of serious harm is low, but long-term exposure above safety limits may increase cancer risk. flag Patients should not stop taking the medication abruptly, as this could lead to rebound hypertension or other complications. flag They are advised to check their medication’s lot number, consult their healthcare provider, and discuss safe alternatives. flag The recall follows similar actions on other drugs, highlighting ongoing concerns about nitrosamine contamination in pharmaceuticals.

23 Articles

Further Reading